Article Details
Retrieved on: 2024-05-28 17:01:12
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Jazz Pharmaceuticals Plc failed to escape Avadel Pharmaceuticals Plc's antitrust counterclaims alleging it improperly listed a patent for Xyrem to ...
Article found on: news.bloomberglaw.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here